Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 15 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Carcinoma 2 Spinocerebellar Degenerations 1 Rectal Neoplasms 1 Neoplasms 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Diseases 1 Advanced Colorectal Cancer 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Paclitaxel 20 Gemcitabine 16 Dexamethasone 16 Bevacizumab 16 Docetaxel 15 Oxaliplatin 14 Cyclophosphamide 13 Carboplatin 12 Capecitabine 12 Sorafenib 11 Fluorouracil 11 Leucovorin 10 Cisplatin 10 pembrolizumab 9 Prednisone 9 Pemetrexed 9 Epoetin Alfa 9 venetoclax 8 atezolizumab 8 Fentanyl 8 Drug Therapy 8 Doxorubicin 8 Rivaroxaban 7 Rituximab 7 Darbepoetin alfa 7 Anastrozole 7 Panitumumab 6 Ondansetron 6 Morphine 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT07270991 2026-02-05

FRUQUITAS

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡